ElyssaMed SAS Company Profile, Contacts & Intelligence

ElyssaMed SAS Overview

ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction.

Headquarters

Paris, Fr

Website

elyssamed.com

Industry

Biotechnology Research

Founded

2015

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Company Email

Available in AeroLeads

ElyssaMed SAS Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

ElyssaMed SAS People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to ElyssaMed SAS

Explore companies in related markets and compare their industry and employee estimates.